Cryo Cell International Inc
CCEL- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0000862692
No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Cryo Cell International Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −5 vs. Q4 2025
- Shares held
- 532.7K
- −299.2K (−36.0%) vs. Q4 2025
- Total value
- $1.89M
- −$970.2K (−33.9%) vs. Q4 2025
- New holders
- 2
- 2 more added
- Sold out
- 7
- 2 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $1.77M |
| Q1 2026 | 11 | $1.89M |
| Q4 2025 | 17 | $3.38M |
| Q3 2025 | 20 | $4.59M |
| Q2 2025 | 20 | $5.17M |
| Q1 2025 | 21 | $6.57M |
| Q4 2024 | 20 | $7.64M |
| Q3 2024 | 14 | $5.74M |
| Q2 2024 | 14 | $6.82M |
| Q1 2024 | 14 | $6.52M |
| Q4 2023 | 15 | $4.97M |
| Q3 2023 | 12 | $4.43M |
| Q2 2023 | 12 | $5.04M |
| Q1 2023 | 12 | $2.50M |
| Q4 2022 | 14 | $4.33M |
| Q3 2022 | 14 | $4.25M |
| Q2 2022 | 13 | $4.45M |
| Q1 2022 | 12 | $5.70M |
| Q4 2021 | 14 | $10.1M |
| Q3 2021 | 10 | $7.88M |
| Q2 2021 | 3 | $1.30M |
| Q1 2021 | 2 | $895.0K |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Cryo Cell International Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SFI Advisors, LLC | 165,300 | $586.8K | 0.62% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 161,524 | $573.4K | 0.00% | +161,524 | New |
| Massmutual Trust Co FSB | 111,035 | $394.2K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 43,616 | $154.9K | 0.00% | −9,553−18.0% | Reduced |
| Vanguard Fiduciary Trust Co | 23,346 | $82.9K | 0.00% | +23,346 | New |
| BlackRock, Inc. | 13,983 | $49.6K | 0.00% | +1,118+8.7% | Added |
| Susquehanna International Group, LLP | 10,018 | $35.6K | 0.00% | −2,235−18.2% | Reduced |
| Advisor Group Holdings, Inc. | 2,500 | $8.88K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 672 | $2.39K | 0.00% | +459+215.5% | Added |
| Morgan Stanley | 601 | $2.13K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 100 | $355 | 0.00% | 00.0% | Unchanged |
| Hamilton Lane Advisors LLC | 0 | $0 | 0.00% | −409,734−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −28,716−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −19,563−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,525−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,222−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |